194 related articles for article (PubMed ID: 22217951)
41. Response to Calver et al. on the WA regulatory scheme for stimulants.
Stevens M
Aust N Z J Public Health; 2008 Apr; 32(2):182. PubMed ID: 18412693
[No Abstract] [Full Text] [Related]
42. Treatment of attention-deficit-hyperactivity disorder.
Elia J; Ambrosini PJ; Rapoport JL
N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
[No Abstract] [Full Text] [Related]
43. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
Hodgkins P; Sasané R; Meijer WM
Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
[TBL] [Abstract][Full Text] [Related]
44. Attention deficit hyperactivity disorder. Issues from a general practice perspective.
Mitchell G; Shaw K
Aust Fam Physician; 2000 Dec; 29(12):1198-201. PubMed ID: 11140233
[No Abstract] [Full Text] [Related]
45. Lisdexamfetamine dimesylate (Vyvanse) for ADHD.
Med Lett Drugs Ther; 2007 Jul; 49(1265):58-9. PubMed ID: 17637583
[No Abstract] [Full Text] [Related]
46. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
Brown TE; Brams M; Gao J; Gasior M; Childress A
Postgrad Med; 2010 Sep; 122(5):7-17. PubMed ID: 20861583
[TBL] [Abstract][Full Text] [Related]
47. [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)].
Käypä hoito suosituksen päivitystiivistelmä
Duodecim; 2012; 128(5):539-40. PubMed ID: 22486070
[TBL] [Abstract][Full Text] [Related]
48. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
49. Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
Brown TE; Brams M; Gasior M; Adeyi B; Babcock T; Dirks B; Scheckner B; Wigal T
Curr Med Res Opin; 2011; 27 Suppl 2():23-33. PubMed ID: 21973229
[TBL] [Abstract][Full Text] [Related]
50. Symposium on attention deficit hyperactivity disorder (ADHD).
Paterson R
Aust N Z J Psychiatry; 2003 Apr; 37(2):242-3; author reply 243. PubMed ID: 12656970
[No Abstract] [Full Text] [Related]
51. Lisdexamfetamine for treatment of attention-deficit/hyperactivity disorder.
Cowles BJ
Ann Pharmacother; 2009 Apr; 43(4):669-76. PubMed ID: 19318601
[TBL] [Abstract][Full Text] [Related]
52. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
53. Lisdexamfetamine dimesylate for childhood ADHD.
Madaan V
Drugs Today (Barc); 2008 May; 44(5):319-24. PubMed ID: 18548134
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
[No Abstract] [Full Text] [Related]
55. Medication and hyperactivity: a meta-analysis.
Thurber S; Walker CE
J Gen Psychol; 1983 Jan; 108(1st Half):79-86. PubMed ID: 6131929
[No Abstract] [Full Text] [Related]
56. Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials.
Surman CB; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):903-8. PubMed ID: 21824454
[TBL] [Abstract][Full Text] [Related]
57. Use of stimulants for attention deficit hyperactivity disorder: FOR.
Coghill D
BMJ; 2004 Oct; 329(7471):907-8. PubMed ID: 15485975
[TBL] [Abstract][Full Text] [Related]
58. Use of stimulants for attention deficit hyperactivity disorder: AGAINST.
Marcovitch H
BMJ; 2004 Oct; 329(7471):908-9. PubMed ID: 15485976
[TBL] [Abstract][Full Text] [Related]
59. Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.
Coghill DR; Banaschewski T; Bliss C; Robertson B; Zuddas A
CNS Drugs; 2018 Jan; 32(1):85-95. PubMed ID: 29383572
[TBL] [Abstract][Full Text] [Related]
60. Self-induced overdose of ADHD medication.
Pearson CC
J Paediatr Child Health; 1996 Jun; 32(3):267. PubMed ID: 8827550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
